Treating HBV with phospholipid prodrugs of .beta.-L-2',3'-dideoxyadenosine 5'-monophosphate
US5990093A · kind A · utility
21Cited by
16References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 1997 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Mar 31, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating HBV infections comprising administering a 5'-phospholipid prodrug of .beta.-L-2',3'-dideoxyadenosine 5'-monophosphate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.